Misoprostol
Cytotec contains the active substance misoprostol. Misoprostol is similar to substances naturally produced in the body, called prostaglandins (in particular prostaglandin E1), which are produced, among other things, in the stomach, duodenum, and intestines.
Cytotec is indicated for the prevention of gastric and duodenal ulcers, which occur during treatment with non-steroidal anti-inflammatory drugs (NSAIDs).
Before taking Cytotec, you should discuss it with your doctor or pharmacist if:
In patients treated with NSAIDs and taking Cytotec, ulcers, perforations, and gastrointestinal bleeding may occur.
Your doctor may decide to perform an endoscopy or biopsy before starting treatment to rule out cancer of the upper gastrointestinal tract.
Improvement of symptoms after taking Cytotec does not exclude the presence of a malignant change in the stomach.
No dose adjustment is necessary.
No dose adjustment is necessary.
The effect of hepatic impairment on the metabolism and plasma concentration of the medicine is small.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take, including those obtained without a prescription.
Studies have not shown any effect of Cytotec on the use of other medicines.
While taking Cytotec, you should avoid taking antacids containing magnesium, as they may increase the diarrhea caused by misoprostol.
In rare cases, concomitant administration of NSAIDs and Cytotec may cause increased aminotransferase activity and peripheral edema.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine.
If you are pregnant or plan to have a child, you should not take Cytotec.
If you become pregnant while taking Cytotec, your doctor will inform you about the risks associated with the treatment, as Cytotec may cause miscarriage, premature birth, or birth defects in the fetus. Pregnancies exposed to misoprostol in the first trimester were associated with an approximately 3-fold increased risk of birth defects in the fetus, particularly facial paralysis, limb defects, and developmental brain and skull defects. If you are exposed to Cytotec during pregnancy, you should discuss it with your doctor. If you decide to continue the pregnancy, you should be closely monitored until delivery and undergo repeated ultrasound examinations, with particular attention to the fetus's limbs and head.
Cytotec should not be used during breastfeeding.
Cytotec should not be used during breastfeeding, as its metabolites pass into human milk, which may cause side effects in breastfed infants (e.g., diarrhea).
Cytotec may cause dizziness, so Cytotec may affect your ability to drive and use machines.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially "sodium-free".
This medicine should always be taken exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose is from 400 micrograms to 800 micrograms per day in two or four divided doses. While taking Cytotec, you should continue to take non-steroidal anti-inflammatory drugs (NSAIDs) as directed by your doctor. If indicated, Cytotec should be taken at the same time as NSAIDs until the end of NSAID therapy. Individual doses of Cytotec should be taken at mealtimes and (or) main meals and before bedtime.
If a higher dose of Cytotec is taken than recommended, the side effects listed below may occur, or existing side effects may worsen. If you take more Cytotec than you should, contact your doctor or pharmacist immediately.
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Very common(may affect more than 1 in 10 people)
diarrhea*, rash
Common(may affect up to 1 in 10 people)
dizziness of central origin, headache, abdominal pain*, constipation, indigestion, bloating, nausea, vomiting, birth defects (fetal developmental abnormalities). If you become pregnant during treatment, you should stop taking Cytotec immediately and seek medical advice.
Uncommon(may affect up to 1 in 100 people)
vaginal bleeding (including bleeding in postmenopausal women), intermenstrual bleeding, menstrual disorders, uterine contractions, fever
Rare(may affect up to 1 in 1,000 people)
menstrual bleeding, painful menstruation, uterine rupture (uterine tear) after administration of prostaglandins in the second or third trimester of pregnancy (mainly in women who have had a previous delivery or have cesarean section scars). You should seek immediate medical attention.
Frequency not known(cannot be estimated from the available data)
anaphylactic reactions, amniotic fluid embolism, abnormal uterine contractions, fetal death, incomplete miscarriage, premature birth, retained placenta, uterine rupture, uterine perforation, uterine hemorrhage, chills.
* Diarrhea and abdominal pain were dose-related, usually occurred in the early stages of treatment, and were self-limiting. In rare cases, severe diarrhea has been reported, leading to severe dehydration.
Selected population groups
No special differences in the safety profile of misoprostol have been observed in patients over 65 years of age compared to younger patients.
The use of misoprostol in children has not been evaluated.
If you experience any side effects, including those not listed in this leaflet, please tell your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder or its representative.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C, protected from light.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after (EXP). The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
White or grayish hexagonal tablets with a score line on both sides, with the inscription "SEARLE 1461" embossed on one side.
Aluminum foil blisters in a cardboard box, containing 30 or 50 tablets.
Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium
Piramal Pharma Solutions (Dutch) B.V., Bargelaan 200, 2333 CW, Leiden, Netherlands
To obtain more detailed information, please contact the representative of the marketing authorization holder:
Pfizer Polska Sp. z o.o., tel.: 22 335 61 00
Date of leaflet approval:07/2024
Detailed and up-to-date information about this product can be obtained by scanning the QR code on the outer packaging using a mobile device. The same information is also available at the URL: https://pfi.sr/ulotka-cytotec and on the website of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products http://www.urpl.gov.pl.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.